Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-16-090125

SVP, CFO, Sec & Treasurer sold 9,564 shares at $8.96 ($85,693)

  • SVP, CFO, Sec & Treasurer acquired 17,032 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kelly James Patrick · SVP, CFO, Sec & Treasurer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2016-01-04 Exercise or conversion : show line 1 in the form +4,688 57,992 D
2016-01-04 Exercise or conversion : show line 2 in the form +2,344 60,336 D
2016-01-04 Exercise or conversion : show line 3 in the form +5,000 65,336 D
2016-01-04 Exercise or conversion : show line 4 in the form +5,000 70,336 D
2016-01-04 Sale : show line 5 in the form −9,564 $8.96 $85,693 60,772 D
Open-market sales · 9,564 sh · avg $8.96 · $85,693

Table II: Derivative

4 lines
Date Transaction Shares Underlying Owned after D/I
2016-01-04 Exercise or conversion : show line 6 in the form Restricted Stock Unit −4,688 4,688 0 D
2016-01-04 Exercise or conversion : show line 7 in the form Restricted Stock Unit −2,344 2,344 2,344 D
2016-01-04 Exercise or conversion : show line 8 in the form Restricted Stock Unit −5,000 5,000 10,000 D
2016-01-04 Exercise or conversion : show line 9 in the form Restricted Stock Unit −5,000 5,000 15,000 D
Loading xslF345X03/doc4.xml…